You are here

  • Home
  • Archive
  • Volume 96, Issue 7
  • Factors associated with interest in bacterial sexually transmitted infection vaccines at two large sexually transmitted infection clinics in British Columbia, Canada

Article Text

Article menu

Download PDFPDF

Health services research
Original research
Factors associated with interest in bacterial sexually transmitted infection vaccines at two large sexually transmitted infection clinics in British Columbia, Canada
  1. Kara M Plotnikoff1,2,3,
  2. Gina Suzanne Ogilvie1,3,4,
  3. Laurie Smith1,5,
  4. Robine Donken1,3,6,
  5. Heather Nicole Pedersen1,3,4,
  6. Hasina Samji2,4,
  7. Troy Grennan4,7
  1. 1 Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, British Columbia, Canada
  2. 2 Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada
  3. 3 School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
  4. 4 British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
  5. 5 Cancer Control Research, BC Cancer, Vancouver, British Columbia, Canada
  6. 6 Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada
  7. 7 Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada
  1. Correspondence to Dr Gina Suzanne Ogilvie, Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, BC V6H 3N1, Canada; gina.ogilvie{at}bccdc.ca

Abstract

Objective To explore sexually transmitted infection (STI) clinic client attitudes and preferences towards STI vaccines and STI vaccine programming in an urban clinic setting.

Methods A 31-item questionnaire was administered during check-in by clinic clerical staff at two STI clinics in Vancouver, Canada. Demographic characteristics and preferences were summarised descriptively. Multivariable logistic regression models to assess factors associated with STI vaccine interest (reported as ORs) were constructed using a priori clinically relevant variables and factors significant at p≤0.05 in bivariate analysis.

Results 293 surveys were included in analysis. 71.3% of respondents identified as male, 80.5% had college level education or higher and 52.9% identified as white/of European descent. The median age was 33. 86.5% of respondents reported they would be interested in receiving an STI vaccine, with a primary motivator to protect oneself. Bivariate analysis indicated several factors associated with vaccine interest, with differences for each infection. After adjusting for other variables, willingness to pay for an STI vaccine (OR=3.83, 95% CI 1.29 to 11.38, p=0.02) remained a significant factor for syphilis vaccine interest and intent to engage in future positive health behaviours remained a significant factor for chlamydia (OR=5.94, 95% CI 1.56 to 22.60, p=0.01) and gonorrhoea (OR=5.13, 95% CI 1.45 to 18.07, p=0.01) vaccine interest.

Conclusion Respondents expressed a strong willingness to receive STI vaccines. These valuable findings will inform for eventual STI vaccine programme planning and implementation.

  • vaccines
  • attitudes
  • infection control
  • bacterial infection
  • vaccination
http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

https://doi.org/10.1136/sextrans-2019-054311

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Handling editor Alec Miners

    • Contributors GSO and TG conceived the project. KMP, GSO, LS, HNP and TG created the survey. KMP entered and analysed data. GSO, LS and RD provided feedback and assistance with analysis. KP wrote the manuscript. GSO, LS, RD, HS and TG provided feedback on initial drafts. All authors reviewed the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Ethics approval This study received ethics approval from the University of British Columbia Research Ethics Board (#H18-02772).

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Data availability statement Data are available on reasonable request.